1. Home
  2. ISPO vs LPTX Comparison

ISPO vs LPTX Comparison

Compare ISPO & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISPO
  • LPTX
  • Stock Information
  • Founded
  • ISPO 2010
  • LPTX 2011
  • Country
  • ISPO United States
  • LPTX United States
  • Employees
  • ISPO N/A
  • LPTX N/A
  • Industry
  • ISPO Blank Checks
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ISPO Finance
  • LPTX Health Care
  • Exchange
  • ISPO Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • ISPO 34.7M
  • LPTX 35.4M
  • IPO Year
  • ISPO N/A
  • LPTX N/A
  • Fundamental
  • Price
  • ISPO $2.89
  • LPTX $0.52
  • Analyst Decision
  • ISPO
  • LPTX Hold
  • Analyst Count
  • ISPO 0
  • LPTX 1
  • Target Price
  • ISPO N/A
  • LPTX N/A
  • AVG Volume (30 Days)
  • ISPO 18.7K
  • LPTX 7.8M
  • Earning Date
  • ISPO 10-28-2025
  • LPTX 11-12-2025
  • Dividend Yield
  • ISPO N/A
  • LPTX N/A
  • EPS Growth
  • ISPO N/A
  • LPTX N/A
  • EPS
  • ISPO N/A
  • LPTX N/A
  • Revenue
  • ISPO $261,225,000.00
  • LPTX N/A
  • Revenue This Year
  • ISPO N/A
  • LPTX N/A
  • Revenue Next Year
  • ISPO $148.66
  • LPTX N/A
  • P/E Ratio
  • ISPO N/A
  • LPTX N/A
  • Revenue Growth
  • ISPO N/A
  • LPTX N/A
  • 52 Week Low
  • ISPO $2.19
  • LPTX $0.22
  • 52 Week High
  • ISPO $7.17
  • LPTX $4.79
  • Technical
  • Relative Strength Index (RSI)
  • ISPO 48.45
  • LPTX 51.58
  • Support Level
  • ISPO $2.82
  • LPTX $0.43
  • Resistance Level
  • ISPO $2.94
  • LPTX $0.56
  • Average True Range (ATR)
  • ISPO 0.08
  • LPTX 0.06
  • MACD
  • ISPO 0.01
  • LPTX -0.02
  • Stochastic Oscillator
  • ISPO 66.67
  • LPTX 31.27

About ISPO Inspirato Incorporated

Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.

Share on Social Networks: